World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
15265
World Ranking
3008
National Ranking
1411

Mark A. Exley publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mark A. Exley sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 173 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mark A. Exley D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark A. Exley sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mark A. Exley is affiliated with Brigham and Women's Hospital in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a substantial focus on subfields including Immunology, Oncology, Genetics, Biotechnology, and Biomedical Engineering.

Their work extensively covers topics such as CAR-T cell therapy research, Immune Cell Function and Interaction, Glioma Diagnosis and Treatment, Cancer Research and Treatments, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, and Nanoplatforms for cancer theranostics.

Mark A. Exley has contributed to numerous publications, including the following notable papers:

  • Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma, 2021, Clinical Cancer Research
  • A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome, 2024, Nature Communications
  • Exploiting CD1-restricted T cells for clinical benefit, 2021, Molecular Immunology
  • A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma, 2023, Journal for ImmunoTherapy of Cancer
  • Challenges and Opportunities for Immunotherapeutic Intervention against Myeloid Immunosuppression in Glioblastoma, 2022, Journal of Clinical Medicine

The scientist frequently publishes in venues such as Regular and Young Investigator Award Abstracts, Cancer Research, Journal of Neuro-Oncology, Frontiers in Immunology, and Neuro-Oncology.

Frequent collaborators in their research include Jenny Zilberberg, Charles Scott, Christopher Uhl, David W. Andrews, and Christopher Cultrara.

Best Publications

  • Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis

    Ivan J. Fuss;Frank Heller;Monica Boirivant;Francisco Leon

  • Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes

    S. Brian Wilson;Sally C. Kent;Kurt T. Patton;Tihamer Orban

  • Multiple immuno-regulatory defects in type-1 diabetes

    Anjli Kukreja;Giulia Cost;John Marker;Chenhui Zhang

  • Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells

    Mark Exley;Jorge A. Garcia;Steven P. Balk;Steven Porcelli

  • Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production

    Lydia Lynch;Lydia Lynch;Michael Nowak;Bindu Varghese;Justice Clark

  • Loss of IFN-gamma production by invariant NK T cells in advanced cancer.

    S M Tahir;O Cheng;A Shaulov;Y Koezuka

  • Cd1-Reactive Natural Killer T Cells Are Required for Development of Systemic Tolerance through an Immune-Privileged Site

    Koh Hei Sonoda;Mark Exley;Scott Snapper;Steven P. Balk

  • Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

    Y N Naumov;K S Bahjat;R Gausling;R Abraham

  • CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung

    Edward E.S. Nieuwenhuis;Tetsuya Matsumoto;Mark Exley;Robbert A. Schleipman

  • NK T Cell-Derived IL-10 Is Essential for the Differentiation of Antigen-Specific T Regulatory Cells in Systemic Tolerance

    Koh-Hei Sonoda;Douglas E. Faunce;Masaru Taniguchi;Mark Exley

  • Efficacy of a therapeutic cocaine vaccine in rodent models

    Barbara S. Fox;Kathleen M. Kantak;Melissa A. Edwards;Kerry M. Black

  • CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains.

    Mark Exley;Steven Porcelli;Margo Furman;Jorge A. Garcia

  • Interplay between the immune system and adipose tissue in obesity.

    Mark Exley;Laura Elizabeth Hand;Donal O'Shea;Lydia Lynch

  • Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice

    Lawrence J. Saubermann;Paul Beck;Ype P. De Jong;Richard S. Pitman

  • Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line.

    P. Clapham;K. Nagy;R. Cheingsong-Popov;M. Exley

  • CD1d and invariant NKT cells at the human maternal-fetal interface.

    Jonathan E. Boyson;Basya Rybalov;Louise A. Koopman;Mark Exley

  • Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester.

    Paul R. Clapham;Robin A. Weiss;Angus G. Dalgleish;Mark Exley

  • CD1d structure and regulation on human thymocytes, peripheral blood T cells,B cells and monocytes

    M. Exley;Jorge A. Garcia;S. B. Wilson;F. Spada

  • Circulating Microparticles as Disease-Specific Biomarkers of Severity of Inflammation in Patients With Hepatitis C or Nonalcoholic Steatohepatitis

    Miroslaw Kornek;Michael Lynch;Shruti H. Mehta;Michelle Lai

  • Disseminated Varicella Infection Due to the Vaccine Strain of Varicella-Zoster Virus, in a Patient with a Novel Deficiency in Natural Killer T Cells

    Ofer Levy;Jordan S. Orange;Patricia Hibberd;Sharon Steinberg

  • CD1d function is regulated by microsomal triglyceride transfer protein.

    Suzana Brozovic;Takashi Nagaishi;Takashi Nagaishi;Masaru Yoshida;Masaru Yoshida;Stephanie Betz

Frequent Co-Authors

Steven P. Balk
Steven P. Balk Beth Israel Deaconess Medical Center
Richard S. Blumberg
Richard S. Blumberg Brigham and Women's Hospital
Lydia Lynch
Lydia Lynch Brigham and Women's Hospital
Steven A. Porcelli
Steven A. Porcelli Albert Einstein College of Medicine
Detlef Schuppan
Detlef Schuppan Johannes Gutenberg University of Mainz
Margaret James Koziel
Margaret James Koziel Harvard Medical School
Scott B. Snapper
Scott B. Snapper Boston Children's Hospital
Jack L. Strominger
Jack L. Strominger Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees online can open diverse career opportunities. Many students begin by considering foundational programs like online adn programs for non nurses. These programs are designed to provide essential clinical and scientific knowledge, making them ideal for people transitioning into the health sciences field.

Accelerated nursing tracks are another popular option, especially for individuals who already hold a degree in another area. The easiest accelerated nursing programs help students fast-track their Bachelor of Science in Nursing, which can be a valuable foundation for understanding immunological principles in patient care.

LPN programs are often a practical starting point for gaining hands-on experience in healthcare settings. Those curious about simpler entry routes can explore easy admission lpn programs, which provide quicker access to nursing roles that closely interact with immune system-related treatments.

For advanced practice roles, nurse practitioner programs with easy admission offer practical specialization options. These programs often include coursework on immunology and infectious diseases, preparing graduates for careers that bridge clinical practice and immunological research.

Best Scientists Citing Mark A. Exley

Trending Scientists